Assessment of cardiovascular findings in FMF related amyloid patients Ailevi akdeniz ateşine ikincil gelişen amiloidozda kardiyovasküler bulguların değerlendirilmesi


Creative Commons License

Köstek O., Takir M., Çalişkan M., Oğuz A.

Medeniyet Medical Journal, cilt.33, sa.3, ss.149-157, 2018 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5222/mmj.2018.05826
  • Dergi Adı: Medeniyet Medical Journal
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.149-157
  • Anahtar Kelimeler: CIMT, E/A ratio, FMF, Secondary amyloidosis
  • Marmara Üniversitesi Adresli: Hayır

Özet

© 2018, Logos Medical Publishing. All rights reserved.Aim: The aim of the study is to compare cardiovascular findings in amyloidosis developed secondary to familial Mediterranean fever (FMF), with those of patient, and healthy control groups. Method: The study was performed on 32 secondary amyloid patients, 33 FMF patients and 65 healthy control individuals. Left ventricular functions were measured using two-dimensional, M-mode, conventional and tissue Doppler echocardiographic images. Aortic elasticity was analyzed using 2-D, M-mode echocardiographic images. Carotid-intima media thickness (CIMT) was measured using carotid artery B-mode ultrasonography. Results: Age, sex and serum lipids were comparable among groups (p>0.05). Aortic wall elasticity properties were similar between groups (p>0.05). Mitral annular E/A ratios were significantly lower in the amyloid group compared with controls ((p=0.004). CIMT was markedly higher in the amyloid group (p=0.001). In addition, CIMT values was higher in FMF patients than healthy controls (p=0.03). Ejection fraction and left ventricular mass index were similar among groups (p>0.05, for both). Conclusion: These findings suggested that subclinical myocardial involvement may be present in patients who developed amyloidosis secondary to FMF: It is noted that CIMT values were higher in patients with secondary amyloidosis.